Kite Pharma (KITE) on Track to Submit KITE-C19 BLA This Year - Investor Day

October 18, 2016 2:58 PM EDT

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Kite Pharma (NASDAQ: KITE) says it is still on track to submit a Biologics License Application (BLA) on KITE-C19 this year, according to Bloomberg, citing today's company webcast.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

FDA, Trader Talk

Add Your Comment